Objective. To describe clinical, biological, radiological presentation and W4 status in COVID-19 elderly patients.Patients and methods. All patients ≥70 years with confirmed SARS-CoV-2 infection and hospitalized in the Infectious Diseases department of the Pitié-Salpêtrière hospital, Paris, France, from March 1 st to April 15 th 2020 were included. The primary outcome was death 4 weeks after hospital admission. Data on demographics, clinical features, laboratory tests, CTscan findings, therapeutic management and complications was collected.Results. Overall, 100 patients were analyzed, including 49 patients ≥80 years. Seventy percent had ≥2 comorbidities. Respiratory features were often severe as 48% needed oxygen support upon admission. Twenty-eight out of 43 patients (65%) with a CT-scan had a mild to severe parenchymal impairment, and 38/43 (88%) a bilateral impairment. Thirty-two patients presented a respiratory distress requiring oxygen support ≥6 liters/minute. Twenty-four deaths occurred, including 21 during hospitalization in our unit, 2 among the 8 patients transferred in ICU, and one at home after discharge from hospital, leading to a global mortality rate of 24% at W4. Age, acute renal failure and respiratory distress were associated with mortality at W4.
Conclusion.Elderly COVID-19 patients with several comorbidities and severe clinical features survived in a substantial proportion, which could argue against transferring the most fragile patients in ICU.